1.
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30.
2.
Wang T, Nelson RA, Bogardus A, Grannis FW, Jr. Five-year lung cancer survival: which
advanced stage non-small cell lung cancer patients attain long-term survival? Cancer.
2010; 116(6):1518-1525.
3.
Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006; 127(4):679-695.
4.
Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. J Exp Med. 2019; 216(5):1016-1026
5.Gloushankova NA, Zhitnyak IY, Rubtsova SN. Role of Epithelial-Mesenchymal Transition
in Tumor Progression. Biochemistry (Mosc). 2018; 83(12):1469-1476.
6.
Cui Q, Ren J, Zhou Q, Yang Q, Li B. Effect of asiatic acid on epithelial-mesenchymal
transition of human alveolar epithelium A549 cells induced by TGF-beta1. Oncol Lett.
2019; 17(5):4285-4292.
7.
Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang L, Liu H, Jia G, Wu L, Hu X ,et al. Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat Commun. 2019; 10(1):1637.
8.
Zhang Y, Li JH, Yuan QG, Cao G, Yang WB. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through
suppressing TGF-beta-induced EMT. J Cell Biochem. 2019; doi.org/10.1002/jcb.28638.
9.Batlle E, Massague J. Transforming Growth Factor-beta Signaling in Immunity and Cancer.
Immunity. 2019; 50(4):924-940.
10.
Chiu HC, Li CJ, Yiang GT, Tsai AP, Wu MY. Epithelial to Mesenchymal Transition and
Cell Biology of Molecular Regulation in Endometrial Carcinogenesis. J Clin Med. 2019;
8(4); doi: 10.3390/jcm8040439.
12.
Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-beta signaling:
Tumorigenesis and targeting for cancer therapy. J Cell Physiol. 2019; 234(8):12173-12187.
13.Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger
AC, Robertson G, et al. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations
in Mediators of Signaling by the TGF-beta Superfamily. Cell Syst. 2018; 7(4):422-437
e427.
14.
Chen G, Ye B. The key microRNAs regulated the development of non-small cell lung cancer
by targeting TGF-beta-induced epithelial-mesenchymal transition. Comb Chem High Throughput
Screen. 2019; doi.org/10.2174/1386207322666190410151945.
15.
Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer
cells and enhances responses to both latent and active TGF-beta. Carcinogenesis. 2011; 32(4):613-621.
16.
Kwiatkowski SC, Guerrero PA, Hirota S, Chen Z, Morales JE, Aghi M, McCarty JH. Neuropilin-1 modulates TGF-beta signaling to drive glioblastoma growth and recurrence after anti-angiogenic therapy. PLoS One. 2017; 12(9):e0185065.
17.Matkar PN, Jong ED, Ariyagunarajah R, Prud'homme GJ, Singh KK, Leong-Poi H. Jack of
many trades: Multifaceted role of neuropilins in pancreatic cancer. Cancer Med. 2018;
7(10):5036-5046.
18.Prud'homme GJ, Glinka Y. Neuropilins are multifunctional coreceptors involved in tumor
initiation, growth, metastasis and immunity. Oncotarget. 2012; 3(9):921-939.
19.Valdembri D, Regano D, Maione F, Giraudo E, Serini G. Class 3 semaphorins in cardiovascular
development. Cell Adh Migr. 2016; 10(6):641-651.
20.
Peng K, Bai Y, Zhu Q, Hu B, Xu Y. Targeting VEGF-neuropilin interactions: a promising
antitumor strategy. Drug Discov Today. 2019; 24(2):656-664.
21.
McGowan SE, McCoy DM. Neuropilin-1 and platelet-derived growth factor receptors cooperatively
regulate intermediate filaments and mesenchymal cell migration during alveolar septation.
Am J Physiol Lung Cell Mol Physiol. 2018; 315(1):L102-L115.
22.
Ding Z, Zhu J, Zeng Y, Du W, Zhang Y, Tang H, Zheng Y, Qin H, Liu Z, Huang JA. The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling. Mol Carcinog. 2019; doi: 10.1002/mc.22990.
23.Jubb AM, Strickland LA, Liu SD, Mak J, Schmidt M, Koeppen H. Neuropilin-1 expression
in cancer and development. J Pathol. 2012; 226(1):50-60.
24.Vivekanandhan S, Mukhopadhyay D. Genetic status of KRAS influences Transforming Growth
Factor-beta (TGF-beta) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis.
Semin Cancer Biol. 2019; 54:72-79.
25.
Jia H, Cheng L, Tickner M, Bagherzadeh A, Selwood D, Zachary I. Neuropilin-1 antagonism
in human carcinoma cells inhibits migration and enhances chemosensitivity. Br J Cancer.
2010; 102(3):541-552.
26.Boschetti G, Kanjarawi R, Bardel E, Collardeau-Frachon S, Duclaux-Loras R, Moro-Sibilot
L, Almeras T, Flourie B, Nancey S, Kaiserlian D. Gut Inflammation in Mice Triggers
Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their
Conversion from CD4+ T Cells. J Crohns Colitis. 2017; 11(1):105-117.
27.Lampropoulou A, Ruhrberg C. Neuropilin regulation of angiogenesis. Biochem Soc Trans.
2014; 42(6):1623-1628.
28.Plein A, Fantin A, Ruhrberg C. Neuropilin regulation of angiogenesis, arteriogenesis,
and vascular permeability. Microcirculation. 2014; 21(4):315-323.
29.
Roy S, Bag AK, Singh RK, Talmadge JE, Batra SK, Datta K. Multifaceted Role of Neuropilins
in the Immune System: Potential Targets for Immunotherapy. Front Immunol. 2017; 8:1228.
30.
Chaudhary B, Khaled YS, Ammori BJ, Elkord E. Neuropilin 1: function and therapeutic
potential in cancer. Cancer Immunol Immunother. 2014; 63(2):81-99.
31.
Sha Y, Haensel D, Gutierrez G, Du H, Dai X, Nie Q. Intermediate cell states in epithelial-to-mesenchymal
transition. Phys Biol. 2019; 16(2):021001.
32.
Liu S, Hou H, Zhang P, Wu Y, He X, Li H, Yan N. Sphingomyelin synthase 1 regulates
the epithelialtomesenchymal transition mediated by the TGFbeta/Smad pathway in MDAMB231
cells. Mol Med Rep. 2019; 19(2):1159-1167.
33.
Hu H, Wang M, Wang H, Liu Z, Guan X, Yang R, Huang R, Tang Q, Zou C, Wang G ,et al.
MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFbeta/SMAD Signaling
Pathway in Colorectal Cancer Metastasis. Cell Physiol Biochem. 2018; 46(5):1895-1906.
34.
Yin J, Wang Y, Chang J, Li B, Zhang J, Liu Y, Lai S, Jiang Y, Li H, Zeng X. Apelin
inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through
downregulating immunoproteasome subunits beta5i. Cell Death Dis. 2018; 9(10):1031.
35.
Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan
A, Koinuma Y, Hayakawa D ,et al. Dasatinib Suppresses TGFbeta-Mediated Epithelial-Mesenchymal
Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Lung. 2018;
196(5):531-541.
36.
Zhang X, Feng W, Zhang J, Ge L, Zhang Y, Jiang X, Peng W, Wang D, Gong A, Xu M. Long
noncoding RNA PVT1 promotes epithelialmesenchymal transition via the TGFbeta/Smad
pathway in pancreatic cancer cells. Oncol Rep. 2018; 40(2):1093-1102.
37.
Glinka Y, Prud'homme GJ. Neuropilin-1 is a receptor for transforming growth factor
beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc
Biol. 2008; 84(1):302-310.
38.
Powell J, Mota F, Steadman D, Soudy C, Miyauchi JT, Crosby S, Jarvis A, Reisinger
T, Winfield N, Evans G ,et al. Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic
and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth
Factor Beta (TGFbeta) Production in Regulatory T-Cells. J Med Chem. 2018; 61(9):4135-4154.
39.Hirota S, Clements TP, Tang LK, Morales JE, Lee HS, Oh SP, Rivera GM, Wagner DS, McCarty
JH. Neuropilin 1 balances beta8 integrin-activated TGFbeta signaling to control sprouting
angiogenesis in the brain. Development. 2015; 142(24):4363-4373.